These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30279335)

  • 21. Genomics of lactation: role of nutrigenomics and nutrigenetics in the fatty acid composition of human milk.
    Sosa-Castillo E; Rodríguez-Cruz M; Moltó-Puigmartí C
    Br J Nutr; 2017 Aug; 118(3):161-168. PubMed ID: 28831952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-Xylose suppresses adipogenesis and regulates lipid metabolism genes in high-fat diet-induced obese mice.
    Lim E; Lim JY; Shin JH; Seok PR; Jung S; Yoo SH; Kim Y
    Nutr Res; 2015 Jul; 35(7):626-36. PubMed ID: 26088373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
    Taskinen MR; Borén J
    Atherosclerosis; 2015 Apr; 239(2):483-95. PubMed ID: 25706066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of genetic variants on lipid parameters and dyslipidemia in a Chinese population.
    Liu Y; Zhou D; Zhang Z; Song Y; Zhang D; Zhao T; Chen Z; Sun Y; Zhang D; Yang Y; Xing Q; Zhao X; Xu H; He L
    J Lipid Res; 2011 Feb; 52(2):354-60. PubMed ID: 21149302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genetic determination of dyslipidemia - What tell us the results of genome-wide association studies?].
    Hubáček JA
    Vnitr Lek; 2016; 62(11):868-876. PubMed ID: 28128572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene-environment interaction in dyslipidemia.
    Cole CB; Nikpay M; McPherson R
    Curr Opin Lipidol; 2015 Apr; 26(2):133-8. PubMed ID: 25692343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update.
    Ooi EM; Watts GF; Ng TW; Barrett PH
    Nutrients; 2015 Jun; 7(6):4416-25. PubMed ID: 26043038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutrigenetics of the lipoprotein metabolism.
    Garcia-Rios A; Perez-Martinez P; Delgado-Lista J; Lopez-Miranda J; Perez-Jimenez F
    Mol Nutr Food Res; 2012 Jan; 56(1):171-83. PubMed ID: 22121097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary fatty acids and lipoprotein metabolism: new insights and updates.
    Ooi EM; Ng TW; Watts GF; Barrett PH
    Curr Opin Lipidol; 2013 Jun; 24(3):192-7. PubMed ID: 23619368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel aspects of PCSK9 and lipoprotein receptors in renal disease-related dyslipidemia.
    Shrestha P; van de Sluis B; Dullaart RPF; van den Born J
    Cell Signal; 2019 Mar; 55():53-64. PubMed ID: 30550765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nutrigenetics and CVD: what does the future hold?
    Lovegrove JA; Gitau R
    Proc Nutr Soc; 2008 May; 67(2):206-13. PubMed ID: 18412994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of known loci with lipid levels among children and prediction of dyslipidemia in adults.
    Tikkanen E; Tuovinen T; Widén E; Lehtimäki T; Viikari J; Kähönen M; Peltonen L; Raitakari OT; Ripatti S
    Circ Cardiovasc Genet; 2011 Dec; 4(6):673-80. PubMed ID: 21984478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diet, lipids, and cardiovascular disease.
    Siri-Tarino PW; Krauss RM
    Curr Opin Lipidol; 2016 Aug; 27(4):323-8. PubMed ID: 27389628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethnic differences in the association between lipid metabolism genes and lipid levels in black and white South African women.
    Ellman N; Keswell D; Collins M; Tootla M; Goedecke JH
    Atherosclerosis; 2015 Jun; 240(2):311-7. PubMed ID: 25864161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid Metabolism and Emerging Targets for Lipid-Lowering Therapy.
    Gaudet D; Drouin-Chartier JP; Couture P
    Can J Cardiol; 2017 Jul; 33(7):872-882. PubMed ID: 28365054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between circulating full-length angiopoietin-like protein 8 and non-high-density lipoprotein cholesterol levels in Chinese non-diabetic individuals: a cross-sectional study.
    Yang S; Jiao X; Huo X; Zhu M; Wang Y; Fang X; Yang Y; Yue W; Qin Y
    Lipids Health Dis; 2018 Jul; 17(1):161. PubMed ID: 30021605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid-Related Genetic Variants for Personalized Dietary Interventions: A Systematic Review.
    Rivera-Íñiguez I; González-Becerra K; Ramos-Lopez O; Peréz-Beltrán YE; Chagüén-Hernández MS; Martínez-López E; Mendivil EJ
    Mol Nutr Food Res; 2023 Jul; 67(14):e2200675. PubMed ID: 37186438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From lipid locus to drug target through human genomics.
    van der Laan SW; Harshfield EL; Hemerich D; Stacey D; Wood AM; Asselbergs FW
    Cardiovasc Res; 2018 Jul; 114(9):1258-1270. PubMed ID: 29800275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary phosphate restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice.
    Tanaka S; Yamamoto H; Nakahashi O; Kagawa T; Ishiguro M; Masuda M; Kozai M; Ikeda S; Taketani Y; Takeda E
    Nutr Res; 2013 Jul; 33(7):586-93. PubMed ID: 23827134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.